[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE8204237L - Karbostyrilforeningar, kompositioner innehallande dessa samt forfaranden for framstellning derav - Google Patents

Karbostyrilforeningar, kompositioner innehallande dessa samt forfaranden for framstellning derav

Info

Publication number
SE8204237L
SE8204237L SE8204237A SE8204237A SE8204237L SE 8204237 L SE8204237 L SE 8204237L SE 8204237 A SE8204237 A SE 8204237A SE 8204237 A SE8204237 A SE 8204237A SE 8204237 L SE8204237 L SE 8204237L
Authority
SE
Sweden
Prior art keywords
pct
preparing
carbostyric
associations
procedures
Prior art date
Application number
SE8204237A
Other languages
English (en)
Other versions
SE8204237D0 (sv
SE440653B (sv
Inventor
T Michiali
Y Yung-Hsiung
O Hidenori
N Kazuyuki
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP55159016A external-priority patent/JPS5782390A/ja
Priority claimed from JP55179950A external-priority patent/JPS57102888A/ja
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of SE8204237D0 publication Critical patent/SE8204237D0/sv
Publication of SE8204237L publication Critical patent/SE8204237L/sv
Publication of SE440653B publication Critical patent/SE440653B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C07D215/28—Alcohols; Ethers thereof with halogen atoms or nitro radicals in positions 5, 6 or 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C07D215/32—Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE8204237A 1980-11-11 1982-07-08 Karbostyrilforeningar SE440653B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP55159016A JPS5782390A (en) 1980-11-11 1980-11-11 Carbostyril derivative
JP55179950A JPS57102888A (en) 1980-12-18 1980-12-18 Carbostyril derivative

Publications (3)

Publication Number Publication Date
SE8204237D0 SE8204237D0 (sv) 1982-07-08
SE8204237L true SE8204237L (sv) 1982-07-08
SE440653B SE440653B (sv) 1985-08-12

Family

ID=26485945

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8204237A SE440653B (sv) 1980-11-11 1982-07-08 Karbostyrilforeningar

Country Status (19)

Country Link
US (1) US4414390A (sv)
EP (1) EP0052016B1 (sv)
KR (1) KR880001657B1 (sv)
AT (1) AT382376B (sv)
AU (1) AU547586B2 (sv)
CA (1) CA1164459A (sv)
CH (1) CH653684A5 (sv)
DE (1) DE3152512T1 (sv)
DK (1) DK157193C (sv)
ES (1) ES507545A0 (sv)
FI (1) FI71145C (sv)
IT (1) IT8149680A0 (sv)
MX (1) MX6802E (sv)
NO (1) NO157819C (sv)
PH (1) PH17158A (sv)
PT (1) PT73959B (sv)
SE (1) SE440653B (sv)
SU (1) SU1215621A3 (sv)
WO (1) WO1982001706A1 (sv)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537889A (en) * 1982-12-27 1985-08-27 Eli Lilly And Company Inotropic agents
US4636502A (en) * 1982-12-27 1987-01-13 Eli Lilly And Company Methods of producing a positive inotropic effect or vasodilation by administration of 2-phenyl imidazo pyrimidines and pyrazines
GB8305245D0 (en) * 1983-02-25 1983-03-30 Fujisawa Pharmaceutical Co Imidazo-heterocyclic compounds
US4533734A (en) * 1983-11-10 1985-08-06 Eli Lilly And Company Inotropic agents
PT79699B (en) * 1983-12-22 1986-12-10 Pfizer Process for preparing quinolone inotropic agents
ES8608874A1 (es) * 1984-05-29 1986-09-01 Pfizer Un procedimiento para la preparacion de una 2-(1h)-quinolona
US4721721A (en) * 1984-12-18 1988-01-26 Rorer Pharmaceutical Corporation 6-(4-thiazole) compounds, cardiotonic compositions including the same, and their uses
FR2580646A1 (fr) * 1985-04-19 1986-10-24 Synthelabo Derives de 2(1h)-quinolinone, leur preparation et leur application en therapeutique
US4666913A (en) * 1985-11-22 1987-05-19 William H. Rorer, Inc. Hydroxy and aminothiazolyl-benzodiazinone compounds, cardiotonic compositions including the same, and their uses
GB8529362D0 (en) * 1985-11-28 1986-01-02 Pfizer Ltd Quinolone cardiac stimulants
GB8619902D0 (en) * 1986-08-15 1986-09-24 Pfizer Ltd Quinolone cardiac stimulants
GB8709448D0 (en) * 1987-04-21 1987-05-28 Pfizer Ltd Heterobicyclic quinoline derivatives
US5840732A (en) * 1994-06-20 1998-11-24 Takeda Chemical Industries Ltd. Imidazopyridine or imidazopyrimidine compounds, their production and use
DE10117184A1 (de) * 2001-04-05 2002-10-17 Gruenenthal Gmbh Substituierte Imidazol[1,2-a]-pyridin-3-yl-amid- und -aminverbindungen
DE10247271A1 (de) * 2002-10-10 2004-08-26 Grünenthal GmbH Substituierte C-Imidazo[1,2-a]pyridin-3-yle
PE20050211A1 (es) * 2003-04-02 2005-04-27 Novartis Ag Procedimiento para preparar oxi-(1h)-quinolin-2-onas 5-(alfa-haloacetil)-8-sustituidas
DE102005019181A1 (de) * 2005-04-25 2006-10-26 Novartis Ag Peptid-Deformylase (PDF) Inhibitoren 1
CN102216298B (zh) 2008-09-16 2014-04-16 Csir公司 作为hiv-1逆转录酶抑制剂的咪唑并吡啶和咪唑并嘧啶
ES2362894B1 (es) * 2009-11-16 2012-05-21 Ferrer Internacional S.A. Procedimiento de preparación del �?cido 4-nitro-oxi-metil-benzoico.
EP3280716B1 (de) 2015-04-08 2020-02-12 Bayer CropScience AG Imidazo[1,2-a]pyridin-2-yl-derivate als schädlingsbekämpfungsmittel und deren zwischenprodukte
CN108137514A (zh) 2015-07-30 2018-06-08 百时美施贵宝公司 芳基取代的二环杂芳基化合物
EP3484894B1 (en) * 2016-07-14 2020-08-19 Bristol-Myers Squibb Company Tricyclic heteroaryl-substituted quinoline and azaquinoline compounds as par4 inhibitors
US20190292176A1 (en) * 2016-07-14 2019-09-26 Bistol-Myers Squibb Company Bicyclic heteroaryl substituted compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1473819A (en) * 1976-01-28 1977-05-18 Gallardo Antonio Sa Derivatives of imidazo 1,2-a pyridine
EP0007525A1 (de) * 1978-07-18 1980-02-06 Hoechst Aktiengesellschaft 2-(4-Aminopiperidino)-3,4-dihydrochinoline, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen sowie ihre Verwendung
ES482439A0 (es) * 1978-07-18 1980-04-01 Hoechst Ag Procedimiento para la preparacion de nuevos derivados de 1-(4-aminopiperidino)-3,4-dihidroisoquinoleina.
JPS5553284A (en) * 1978-10-12 1980-04-18 Yoshitomi Pharmaceut Ind Ltd Pyridazinone derivative
GB2031404A (en) * 1978-10-17 1980-04-23 Yoshitomi Pharmaceutical Pyridazinone compounds

Also Published As

Publication number Publication date
PT73959A (en) 1981-12-01
NO157819C (no) 1988-05-25
CA1164459A (en) 1984-03-27
AT382376B (de) 1987-02-25
ATA908381A (de) 1986-07-15
PH17158A (en) 1984-06-13
DK307482A (da) 1982-07-08
FI71145C (fi) 1986-11-24
CH653684A5 (fr) 1986-01-15
NO157819B (no) 1988-02-15
DK157193B (da) 1989-11-20
PT73959B (en) 1983-04-18
EP0052016A1 (en) 1982-05-19
SU1215621A3 (ru) 1986-02-28
FI822471A0 (fi) 1982-07-12
SE8204237D0 (sv) 1982-07-08
FI71145B (fi) 1986-08-14
ES8301967A1 (es) 1983-02-01
ES507545A0 (es) 1983-02-01
US4414390A (en) 1983-11-08
KR880001657B1 (ko) 1988-09-05
IT8149680A0 (it) 1981-11-11
AU547586B2 (en) 1985-10-24
MX6802E (es) 1986-07-29
DE3152512T1 (de) 1982-11-18
AU7808581A (en) 1982-06-07
DK157193C (da) 1990-04-09
EP0052016B1 (en) 1984-09-05
DE3152512C2 (sv) 1991-01-03
FI822471L (fi) 1982-07-12
WO1982001706A1 (en) 1982-05-27
NO822391L (no) 1982-07-09
SE440653B (sv) 1985-08-12
KR830007644A (ko) 1983-11-04

Similar Documents

Publication Publication Date Title
SE8204237D0 (sv) Karbostyrilforeningar, kompositioner innehallande dessa samt forfaranden for framstellning derav
SE8302693L (sv) Heterocykliska foreningar
BR9303993A (pt) Composto, processo para preparar o mesmo e composição farmacêutica
ES485188A1 (es) Procedimiento para preparar 1-piperazina-carboxamidas y car-botiamidas
SE8700498D0 (sv) Novel pharmaceologically active compounds
MD4B1 (ro) Remediu erbicid
ES2074846T3 (es) Nuevas naftil-etil-ureas y naftil-etil-tioureas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
SE8200916L (sv) Karbostyrilderivat, forfarande for framstellning derav och hjertsterkande komposition som innehaller detsamma
IL57577A0 (en) 1,2-dihydroquinolin-2-one derivatives,process for their preparation and pharmaceutical compositions containing the same
SE7707341L (sv) 4-hydroxifenylalkanolamin-derivat och forfarande for framstellning derav
ES8300729A1 (es) Un procedimiento para la produccion de un derivado de pripe-razina.
NO960632D0 (no) Nye bis-naftalimider for behandling av kreft
DE69330601D1 (de) Serotoninergische ergolin derivate
AU530678B2 (en) Phosphono-hydroxy-acetic acid
ES8304122A1 (es) "procedimiento para la preparacion de derivados triptaminicos sustituidos de tieniloxipropanolaminas, racemicos y opticamente activos".
DK532679A (da) Fremgangsmaade til fremstilling af 2-aryl-3,4-diaza-bicyclo (4,1,0)hepten-(2)-on-(5).
GB1126002A (en) New basic ethers and process for preparing same
NZ220800A (en) Tetrahydrobenzothiazoles and pharmaceutical compositions
ES8307778A1 (es) Procedimiento para preparar difenilbutil-1-piperazinocarboxilatos.
ES8106129A1 (es) Un procedimiento para la preparacion de derivados de ciclo- hexadieno
NO904708D0 (no) Fremgangsmaate for fremstilling av derivater av 2-(3-pyridyl)-2-tetrahydrotiopyrankarbotioamid-1-oksid-(1r-2r).
SE7907656L (sv) 3,4-dihydroxikanelaldehydderivat
DE3270999D1 (de) N-substituted-tetrahydroisophthalimide derivatives
ES8602619A1 (es) Un procedimiento para la preparacion de amidas del acido propionico.
AU564739B2 (en) Acridanone derivatives

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8204237-5

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8204237-5

Format of ref document f/p: F